The Impact of Warmed Carbon Dioxide Insufflation During Colonoscopy on Polyp Detection

Sponsor
Queen's University (Other)
Overall Status
Terminated
CT.gov ID
NCT02065037
Collaborator
(none)
229
1
2
15
15.3

Study Details

Study Description

Brief Summary

Colorectal cancer is the second most common cancer in the world and the second leading cause of cancer-related mortality. Colorectal cancers arise from precursor adenomatous polyps in a well characterized adenoma to carcinoma progression. The removal of such precursor lesions reduces colorectal cancer mortality between 30 to 50%. Colonoscopy is used for detection of neoplastic polyps but significant miss rates of such lesions are reported. Methods to reduce spasm of the colon have been investigated to increase adenoma detection rates including the use of warm water irrigation and hyoscine butyl bromide. Carbon dioxide warmed to body temperature is postulated to have spasmolytic effects. Administration of warmed carbon dioxide during colonoscopy may improve polyp detection.

Objective: In this study, colonoscopy using warmed carbon dioxide insufflation will be compared to standard room temperature air insufflation to see if there is a greater detection of polyps per patient.

Methods: Patients undergoing colonoscopy for screening and surveillance indications will be included and randomized to receive either room temperature room air or warmed carbon dioxide (37 degrees Celsius). Endoscopists and patients will be blinded to the intervention. Data on indication, preparation, sedation, withdrawal time will be recorded. Polyp detection rate will be the primary outcome. Secondary outcomes will include adenoma detection rate and advanced lesion detection rates.

Condition or Disease Intervention/Treatment Phase
  • Device: room temperature air insufflation
  • Device: warmed carbon dioxide insufflation
N/A

Detailed Description

study terminated

Study Design

Study Type:
Interventional
Actual Enrollment :
229 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Diagnostic
Official Title:
The Impact of Warmed Carbon Dioxide Insufflation During Colonoscopy on Polyp Detection: A Randomized Controlled Trial
Study Start Date :
Jun 1, 2014
Actual Primary Completion Date :
Sep 1, 2015
Actual Study Completion Date :
Sep 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Experimental: Warmed Carbon Dioxide Insufflation

warmed carbon dioxide insufflation used in colonoscopy

Device: warmed carbon dioxide insufflation
comparator arm

Active Comparator: Room Temperature Air Insufflation

room temperature air insufflation used in colonoscopy

Device: room temperature air insufflation
control arm

Outcome Measures

Primary Outcome Measures

  1. Polyp Detection Rate [time of endoscopy]

Secondary Outcome Measures

  1. adenoma detection rate [2 weeks]

  2. advanced lesion per patient detection rate [2 weeks]

Other Outcome Measures

  1. cecal intubation rate [day of colonoscopy]

  2. withdrawal time [day of colonoscopy]

  3. anesthetic doses [day of colonoscopy]

  4. quality of bowel preparation [day of colonoscopy]

  5. patient comfort by a validated nurse administered comfort score [day of colonoscopy]

Eligibility Criteria

Criteria

Ages Eligible for Study:
40 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

-outpatients undergoing routine screening or surveillance colonoscopy for colorectal cancer and / or polyp surveillance at Hotel Dieu Hospital

Exclusion Criteria:
  • patients who have undergone colonic resections

  • active inflammatory bowel disease

  • hereditary polyposis syndromes

  • moderate to severe chronic obstructive pulmonary disease

  • obstructive sleep apnea requiring continuous positive airway pressure or biphasic positive airway pressure

  • neurologic diagnoses affecting ventilation

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hotel Dieu Hospital Kingston Ontario Canada K7L5G2

Sponsors and Collaborators

  • Queen's University

Investigators

  • Principal Investigator: Lawrence Hookey, MD, Queens University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Dr. Lawrence Hookey, Assistant Professor and Director of Endoscopy, Queen's University
ClinicalTrials.gov Identifier:
NCT02065037
Other Study ID Numbers:
  • 6011440
  • DMED-1658-13
First Posted:
Feb 17, 2014
Last Update Posted:
Feb 16, 2017
Last Verified:
Feb 1, 2017
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by Dr. Lawrence Hookey, Assistant Professor and Director of Endoscopy, Queen's University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 16, 2017